An interaction between the treatment of the sexual dysfunction and the reduced risk of the heart attacks

Medications from the PDE5 inhibitor group are used to treat the erectile dysfunction in the modern practice. The first representative of this group has been Sildenafil.

Pfizer company developing this ingredient for the treatment of the cardiovascular diseases have found out that a positive effect on the potency is higher than on the cardiovascular system. Continue reading